Novo Nordisk's Profit Rises 43%,
At Top End of Analysts' Estimates

Dow Jones Newswires

Updated Nov. 2, 2000 12:27 p.m. ET

COPENHAGEN -- Novo Nordisk A/S posted a 43% jump in pretax profit in the first nine months of 2000, boosted by currency gains and strong sales in both its pharmaceutical and enzyme-production businesses.

Denmark's largest drugs company also upgraded its full-year operating profit forecast to around 30% growth for the full year, provided currency...